High-flow nasal cannula supportive therapy in chronic heart failure: A partial or completed "CPAP-like effect"?

Journal of Critical Care

Volumn 29, Issue 3, 2014, Pages 465-

  Esquinas, Antonio M ^a   Papadakos, Peter J ^b  

^a HOSPITAL MORALES MESEGUER   (Spain)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREATHING PATTERN; BREATHING RATE; CARBON DIOXIDE TENSION; CHEYNE STOKES BREATHING; ECHOCARDIOGRAPHY; END EXPIRATORY POSITIVE PRESSURE; GAS EXCHANGE; HEART FAILURE; HEART RATE; HIGH FLOW NASAL CANNULA; HUMAN; HYPERVENTILATION; INFERIOR CAVA VEIN; LETTER; LUNG VOLUME; NASAL CANNULA; NONINVASIVE VENTILATION; POSITIVE END EXPIRATORY PRESSURE; FEMALE; MALE; OXYGEN THERAPY; PROCEDURES;

FEMALE; HEART FAILURE; HUMANS; MALE; OXYGEN INHALATION THERAPY;

EID: 84899919407     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.01.024     Document Type: Letter

References (10)

1. Peacock W.F. Using the emergency department clinical decision unit for acute decompensated heart failure. Cardiol Clin 2005, 23(4):569-588.
2. Ricard J.D. High flow nasal oxygen in acute respiratory failure. Minerva Anestesiol 2012, 78(7):836-841.
3. Roca O., Pérez-Terán P., Masclans J.R., Pérez L, Galve E, Evangelista A, et al. Patients with New York Heart Association class III heart failure may benefit with high flow nasal cannula supportive therapy: high flow nasal cannula in heart failure. J Crit Care 2013, 28:741-746.
4. Reis M.S., Arena R., Archiza B., de Toledo CF, Catai AM, Borghi-Silva A Deep breathing heart rate variability is associated with inspiratory muscle weakness in chronic heart failure. Physiother Res Int 2013, 10.1002/pri.1552.
5. Leung R.S., Floras J.S., Bradley T.D. Respiratory modulation of the autonomic nervous system during Cheyne-Stokes respiration. Can J Physiol Pharmacol 2006, 84(1):61-66.
6. Lorenzi-Filho G., Genta P.R., Figueiredo A.C., Inoue D Cheyne-Stokes respiration in patients with congestive heart failure: causes and consequences. Clinics (Sao Paulo) 2005, 60:333-344.
7. 2O for 1year in five cases. Respiration 2005, 72:198-201.
8. Chanques G., Riboulet F., Molinari N., et al. Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. Minerva Anestesiol 2013, 79(12):1344-1355.
9. Chiumello D., Esquinas A.M., Moerer O., et al. A systematic technical review of the systems for the continuous positive airway pressure. Minerva Anestesiol 2012, 78(12):1385-1393.
10. Scala R., Naldi M. Ventilators for noninvasive ventilation to treat acute respiratory failure. Respir Care 2008, 53(8):1054-1080.